First Choice Healthcare Solutions Inks $650M SPAC Deal with Westin Acquisition Corp.
FCHS has more than doubled off its 52-week low of $0.002 on elevated volume (5.6× avg).
Summary
Financially distressed First Choice Healthcare Solutions announced a SPAC merger with Westin Acquisition Corp. at an equity value of up to $650 million, alongside a $10 million PIPE and acquisitions of the Pointe Med Entities.
Key Events · M&A and Partnerships · FCHS
-
SPAC Merger Agreement Signed
On July 22, 2026, the company entered into a Business Combination Agreement with Westin Acquisition Corp. (Nasdaq: WSTN), valuing First Choice at an equity value of up to approximately $650 million. The combined company will be named Wellgevity 360, Inc. and is expected to trade on Nasdaq.
-
Concurrent PIPE Investment
A $10 million PIPE investment for shares of PubCo Preferred Stock with a stated value of $12.5 million was agreed to, to be consummated at closing.
-
Acquisition of Pointe Med Entities
Binding agreements were entered into to acquire all outstanding equity interests of Pointe Medical Services, LLC, Point Medical Pharmacy, Inc., Live Well Drugstore, LLC, and Live Well Drugstore, Inc., to be consummated concurrently with the merger closing.
-
Post-Merger Governance
The initial board of the combined company will consist of five directors: one independent director designated by the Sponsor, three independent directors designated by the Company, and the Company's CEO. The Company will designate the initial Chairperson.
Analysis · FCHS · Industrial Applications And Services
A near-zero-revenue company with a going-concern warning, First Choice Healthcare Solutions, has signed a definitive agreement to go public via a SPAC merger at an implied equity value of up to $650 million. The deal includes a concurrent $10 million PIPE investment and the acquisition of the Pointe Med Entities. While the valuation appears aspirational given the company's financial distress, the transaction provides a path to Nasdaq listing and access to capital. The merger is subject to shareholder approvals, SEC effectiveness, and other closing conditions, with an outside date in early 2027. The announcement is a dramatic turnaround narrative for a company that was on the brink, but execution risk is extremely high.
At the time of this filing, FCHS was trading at $0.01 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $395.5K. The 52-week trading range was $0.00 to $0.51. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.